Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer-Reference-Cited by-同舟云学术

Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer

Published:2016-11 Issue: Volume:68 Page:163-172
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Bouchahda Mohamed,Boige Valérie,Smith Denis,Karaboué Abdoulaye,Ducreux Michel,Hebbar Mohamed,Lepère Céline,Focan Christian,Guimbaud Rosine,Innominato Pasquale,Awad Sameh,Carvalho Carlos,Tumolo Salvatore,Truant Stephanie,De Baere Thierry,Castaing Denis,Rougier Philippe,Morère Jean-François,Taieb Julien,Adam René,Lévi Francis

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial;Heinemann;Lancet Oncol,2014

2. Molecularly targeted drugs for metastatic colorectal cancer;Cheng;Drug Des Devel Ther,2013

3. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer;Van Cutsem;N Engl J Med,2009

4. Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer;Bokemeyer;J Clin Oncol,2009

5. EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer;Sobrero;J Clin Oncol,2008

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Maintenance Therapy Using Cetuximab in Patients with Metastatic Colorectal Cancer: Retrospective Study;Cancer Management and Research;2024-03

2. Outcomes and prognostic factors in initially unresectable hepatocellular carcinoma treated using conversion therapy with lenvatinib and TACE plus PD-1 inhibitors;Frontiers in Oncology;2023-01-30

3. Hepatic Artery Infusion Therapy: The European Experience;Colorectal Liver Metastasis;2022

4. Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS;Scientific Reports;2017-12

5. Optimal detection of clinically relevant mutations in colorectal carcinoma: sample pooling overcomes intra-tumoral heterogeneity;Modern Pathology;2017-10-13